Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

129.65 -0.07 (-0.05%)
Official Closing Price Updated: 7:59 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Moderna Inc

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Moderna to Present at MIT Lecture Series
Moderna to present at MIT Distinguished Lecture Series. 
From Business Wire News Releases
Pharmaceutical Development Ramp up as Viral Infections Continue to Threaten
FinancialBuzz.com News Commentary 
From PR Newswire
Biotechs and Big Pharma in a Race Against Time Battling Global Health Crisis
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Biotechs and Big Pharma in a Race Against Time Battling Global Health Crisis
Financialnewsmedia.com News Commentary 
From PR Newswire
Biotech Companies Concentrate on Vaccine Formulation and Distribution
FinancialBuzz.com News Commentary 
From PR Newswire
Thinking about buying stock in Cognex, Kroger, Moderna, Nio, or Vaxart?
InvestorsObserver issues critical PriceWatch Alerts for CGNX, KR, MRNA, NIO, and VXRT. 
From PR Newswire
Coronavirus Puts Drug Repurposing on the Fast Track
Financialnewsmedia.com News Commentary 
From PR Newswire
Coronavirus Puts Drug Repurposing On The Fast Track
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Moderna Announces First Participant Dosed in NIH-led Phase 1 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
Moderna announces first participant dosed in NIH-led Phase 1 study of mRNA vaccine (mRNA-1273) against novel coronavirus. 
From Business Wire News Releases
Thinking about buying stock in Ford, Moderna, Progressive, AT&T, or Visa?
InvestorsObserver issues critical PriceWatch Alerts for F, MRNA, PGR, T, and V. 
From PR Newswire
Innovations Abound in the Fight Against COVID-19
FinancialBuzz.com News Commentary 
From PR Newswire
Flagship Pioneering Announces the Launch of Repertoire Immune Medicines with Industry Veteran John G. Cox as Chief Executive Officer
Flagship Pioneering, a life sciences innovation enterprise, announced the launch of Repertoire Immune Medicines, a clinical-stage biotechnology company tapping the curative powers of our immune system... 
From Business Wire News Releases
Limiting Coronavirus Exposure, WHO Urging Stepped up Measures to Combat Virus
Financialnewsmedia.com News Commentary 
From PR Newswire
Limiting Coronavirus Exposure, WHO Urging Stepped Up Measures to Combat Virus
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Moderna Completes Enrollment of Cytomegalovirus (CMV) Vaccine (mRNA-1647) Phase 2 Study
Moderna completes enrollment of cytomegalovirus (CMV) vaccine (mRNA-1647) Phase 2 study. 
From Business Wire News Releases
Aggressive Infectious Diseases Prompt the Development of Powerful New Blood Tests
FinancialBuzz.com News Commentary 
From PR Newswire
Moderna Announces Updated Plans for its March 4 Manufacturing & Digital Day Event
Moderna announces updated plans for its March 4 Manufacturing & Digital Day event. 
From Business Wire News Releases
Governments Spring to Action as Coronavirus Fears Grow
FinancialBuzz.com News Commentary 
From PR Newswire
Moderna to Host Manufacturing & Digital Day on March 4, 2020
Moderna to host Manufacturing & Digital Day on March 4 at the Company’s manufacturing facility in Norwood, MA. 
From Business Wire News Releases
Latest Viral Outbreak Reinforces the Need for Modern Containment Measures
FinancialBuzz.com News Commentary 
From PR Newswire
Moderna Reports 2019 Fourth Quarter and Full Year Financial Results and Highlights Advancements in Core Modalities
Moderna reports 2019 fourth quarter and full year financial results and highlights advancements in core modalities. 
From Business Wire News Releases
Moderna Ships mRNA Vaccine Against Novel Coronavirus (mRNA-1273) for Phase 1 Study
Moderna ships mRNA vaccine against novel coronavirus (mRNA-1273) to the NIH to be used in the planned Phase 1 study in the U.S. 
From Business Wire News Releases
Moderna to Present at Upcoming Investor Conferences
Moderna to present at upcoming investor conferences. 
From Business Wire News Releases
Moderna to Report Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26th, 2020
Moderna to report fourth quarter and full year 2019 financial results on Wednesday, February 26th, 2020. 
From Business Wire News Releases
Moderna Announces Pricing of Public Offering of Shares of Common Stock
Moderna announces pricing of public offering of shares of common stock. 
From Business Wire News Releases
Moderna Announces Progress in Prophylactic Vaccines Modality with CMV Vaccine Phase 2 Study Data Now Expected in Third Quarter 2020 and Expands Investment in This Core Modality with Three New Developm
Moderna announces progress in prophylactic vaccines modality with CMV vaccine Phase 2 study data now expected in third quarter 2020. 
From Business Wire News Releases
Moderna Announces First Patient Enrolled in Phase 1/2 Study of mRNA-3704 for Methylmalonic Acidemia
Moderna announces first patient enrolled in Phase 1/2 study of mRNA-3704 for methylmalonic acidemia. 
From Business Wire News Releases
Moderna Announces Proposed Public Offering of Shares of Common Stock
Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today... 
From Business Wire News Releases
Coronavirus Outbreak Sparks Renewed Interest in Combatting Infectious Diseases
FinancialBuzz.com News Commentary 
From PR Newswire
Sandra Horning, M.D. To Join Moderna’s Board of Directors
Sandra Horning, M.D. to join Moderna’s Board of Directors. 
From Business Wire News Releases
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.